Treatments using antibodies of pandemic survivors enters new Phase 2 evaluation
Researchers and clinical experts at Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, continue their work on convalescent plasma treatments for COVID-19 patients – now with a new Phase 2 study.